FDA Inspection 1226525 — Precipart Corp
The FDA completed an inspection of Precipart Corp on December 20, 2023 in Farmingdale, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 20, 2023
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Farmingdale, NY (United States)